Simultaneous Branch Retinal Artery and Central Retinal Vein Occlusion Improved with No Ocular Therapy: A Case Report.

BRAO CRVO branch retinal artery occlusion central retinal vein occlusion multimodal imaging

Journal

Tomography (Ann Arbor, Mich.)
ISSN: 2379-139X
Titre abrégé: Tomography
Pays: Switzerland
ID NLM: 101671170

Informations de publication

Date de publication:
19 09 2023
Historique:
received: 11 08 2023
revised: 17 09 2023
accepted: 18 09 2023
medline: 25 9 2023
pubmed: 22 9 2023
entrez: 22 9 2023
Statut: epublish

Résumé

A rarely described condition known as branch retinal artery occlusion (BRAO) with concurrent obstruction of the central retinal vein (CRVO) is characterized by diffuse retinal hemorrhages, dilated and tortuous retinal veins, macular and disc edema, cotton wool spots, and a generalized delay in arteriovenous transit on fluorescein angiography, together with a retinal whitening in the area of the affected retinal arterial branch. Although BRAO and CRVO may share underlying systemic risk factors, the pathogenesis of combined BRAO + CRVO is still unknown. We present a BRAO + CRVO case report concerning a 63-year-old white male who came to our observation complaining of sudden vision loss in his right eye. An increased risk for thrombotic event was revealed in this case, and the patient improved only with systemic anticoagulant therapy and in the absence of ocular therapy. We also explain all the clinical findings that are detectable using different diagnostic devices and analyze the scientific literature for other, similar clinical cases.

Identifiants

pubmed: 37736992
pii: tomography9050139
doi: 10.3390/tomography9050139
pmc: PMC10514818
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

1745-1754

Références

Case Rep Ophthalmol. 2015 Feb 23;6(1):76-81
pubmed: 25873891
Eur J Ophthalmol. 2005 Nov-Dec;15(6):811-4
pubmed: 16329072
Am J Ophthalmol. 2022 Apr;236:136-146
pubmed: 34283978
Trans Am Ophthalmol Soc. 1979;77:191-209
pubmed: 583535
Eye (Lond). 2001 Apr;15(Pt 2):225-7
pubmed: 11339596
Am J Ophthalmol. 2014 Aug;158(2):372-380.e1
pubmed: 24794089
Retin Cases Brief Rep. 2021 Sep 1;15(5):519-522
pubmed: 30365416
Cureus. 2017 Aug 23;9(8):e1600
pubmed: 29067224
Eye (Lond). 2016 Jun;30(6):888-93
pubmed: 27034199
Ophthalmology. 2020 Feb;127(2):P288-P320
pubmed: 31757503
Retina. 2008 Apr;28(4):581-94
pubmed: 18398361
Prog Retin Eye Res. 2005 Jul;24(4):493-519
pubmed: 15845346
BMJ Case Rep. 2016 Dec 14;2016:
pubmed: 27974343
Thromb Res. 1995 Nov 15;80(4):327-31
pubmed: 8585045
Retina. 2003 Aug;23(4):546-8
pubmed: 12972771
Br J Ophthalmol. 1976 Jun;60(6):419-27
pubmed: 25233547
Cutan Ocul Toxicol. 2012 Sep;31(3):253-7
pubmed: 22172047
Eur J Ophthalmol. 2021 Mar;31(2):NP74-NP76
pubmed: 32106703
Saudi J Ophthalmol. 2021 Feb 27;34(3):212-215
pubmed: 34085018
Case Rep Ophthalmol. 2011 Jan 11;2(1):23-9
pubmed: 21326840
Ophthalmology. 2011 Dec;118(12):2453-60
pubmed: 21764136
BMC Ophthalmol. 2014 Jul 12;14:91
pubmed: 25015220
Indian J Ophthalmol. 2020 Oct;68(10):2136-2142
pubmed: 32971625
Ophthalmology. 2020 Feb;127(2):P259-P287
pubmed: 31757501
Vision (Basel). 2023 Jul 28;7(3):
pubmed: 37606497
Ophthalmologe. 2012 Jan;109(1):71-5
pubmed: 22130725
Retina. 1990;10(2):105-12
pubmed: 1698304
Eye (Lond). 2004 Sep;18(9):942-5
pubmed: 15002016

Auteurs

Livio Vitiello (L)

Eye Unit, "Luigi Curto" Hospital, Azienda Sanitaria Locale Salerno, Polla, 84035 Salerno, Italy.

Giulio Salerno (G)

Eye Unit, "Luigi Curto" Hospital, Azienda Sanitaria Locale Salerno, Polla, 84035 Salerno, Italy.

Alessia Coppola (A)

Eye Unit, "Luigi Curto" Hospital, Azienda Sanitaria Locale Salerno, Polla, 84035 Salerno, Italy.

Giulia Abbinante (G)

Eye Unit, "Luigi Curto" Hospital, Azienda Sanitaria Locale Salerno, Polla, 84035 Salerno, Italy.

Vincenzo Gagliardi (V)

Eye Unit, "Luigi Curto" Hospital, Azienda Sanitaria Locale Salerno, Polla, 84035 Salerno, Italy.

Alfonso Pellegrino (A)

Eye Unit, "Luigi Curto" Hospital, Azienda Sanitaria Locale Salerno, Polla, 84035 Salerno, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH